Beating cancer
starts with knowing
you have it.

Scroll Down to Learn More

Cancer screenings can
detect cancer even before symptoms appear to improve treatment outcomes and survival.¹

Today, only 5 cancer types have recommended screening tests:

Breast

Mammography

Cervical

Pap test

Colorectal

Colonoscopy,
stool-based tests

Lung

Low dose CT (imaging) for people at high-risk

Prostate

Digital rectal exam, PSA test

Other cancer screening tests are available but may not be routinely recommended as the standard of care for all patients.

About 3 out of 4 new cancer cases will be due to cancers with no recommended screening.

In fact, when cancers are diagnosed early, the overall 5-year survival rate is 4 times higher than when diagnosed in later stages.^{3, 4}

The latest scientific advancements in medicine combined with groundbreaking technologies make it possible to screen for more cancers with a multi-cancer early detection test.

The latest scientific advancements in medicine combined with groundbreaking technologies make it possible to screen for more cancers with a multi-cancer early detection test.

What is a multi-cancer early detection test?

Ordered by a doctor, it’s a new way to screen for more cancers with a simple blood draw. Most of these cancers don’t have recommended screening tests.

Screening tests can find signs or signals that cancer may be present, but do not diagnose cancer. Additional tests such as blood work or imaging are needed following a positive test result to determine if cancer is present.

Learn More

Who is at risk for cancer and who could benefit from a multi-cancer early detection test?

• Age is the biggest risk factor for cancer.

• Adults aged 50+ are at elevated risk of cancer and are 13 times more likely to have cancer.⁵

• Less than 10% of all cancers are associated with a genetic risk factor passed down in families.⁶

Sign up and learn more about multi-cancer early detection, available in the US now.

Sign up now

Keep in the know with the Galleri test

Learn more about the Galleri test through email updates.

First name

Last name

Email address

Which of the below best describes you?

I am a Patient

I am a Healthcare Provider

I represent a Healthcare System

I represent an Employer

Submit

By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

A multi-cancer early detection test looks for active cancer and does not predict your future genetic risk for cancer.
A multi-cancer early detection test does not detect all cancers and not all cancers can be detected in the blood.
False positives and false negatives can occur.

REFERENCES

1. Henley SJ, et al. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer. 2020;126(10):2225 – 2249. DOI: doi.org/10.1002/cncr.32802.
   
2. SEER Stat Database: Incidence — SEER 18 Regs Research Data, Nov 2017 Sub. Includes persons aged 50+ diagnosed 2006 – 2015.
3. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence — SEER 18 Regs Research Data. Nov 2018 Sub. Includes persons aged 50 – 79 diagnosed 2006 – 2015.​“Early/​Localized” includes invasive localized tumors that have not spread beyond organ of origin.​“Late/​Metastasized” includes invasive cancers that have metastasized beyond the organ of origin to other parts of the body.
4. Noone AM, Howlader N, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975 – 2015, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2015, based on November 2017 SEER data submission, posted to the SEER website April 2018.
5. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database Incidence — SEER Research Limited-Field Data, 21 Registries, Nov 2020 Sub (2000−2018) — Linked To County Attributes ‑Time Dependent (1990−2018) Income/​Rurality, 1969 – 2019 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2021, based on the November 2020 submission.
6. National Cancer Institute. The Genetics of Cancer. https://www.cancer.gov/about-cancer/causes-prevention/genetics